Chemoinformaics analysis of 2-O-PROP-2-ENYL 1-O-TRIDECYL OXALATE
| Molecular Weight | 312.45 | nRot | 14 |
| Heavy Atom Molecular Weight | 280.194 | nRig | 0 |
| Exact Molecular Weight | 312.23 | nRing | 0 |
| Solubility: LogS | -4.421 | nHRing | 0 |
| Solubility: LogP | 4.184 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 54.6054 |
| nHD | 0 | BPOL | 37.3106 |
| QED | 0.529 |
| Synth | 2.436 |
| Natural Product Likeliness | 0.86 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.005 |
| HIA | 0.005 |
| CACO-2 | -4.193 |
| MDCK | 0.0000195 |
| BBB | 0.922 |
| PPB | 0.940029 |
| VDSS | 1.987 |
| FU | 0.0603056 |
| CYP1A2-inh | 0.775 |
| CYP1A2-sub | 0.86 |
| CYP2c19-inh | 0.162 |
| CYP2c19-sub | 0.937 |
| CYP2c9-inh | 0.425 |
| CYP2c9-sub | 0.503 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.176 |
| CYP3a4-inh | 0.084 |
| CYP3a4-sub | 0.402 |
| CL | 10.666 |
| T12 | 0.318 |
| hERG | 0.014 |
| Ames | 0.009 |
| ROA | 0.046 |
| SkinSen | 0.128 |
| Carcinogencity | 0.074 |
| EI | 0.992 |
| Respiratory | 0.117 |
| NR-Aromatase | 0.003 |
| Antiviral | Yes |
| Prediction | 0.608049 |